Managing high blood pressure is often a long road of trial and error. Doctors frequently have to adjust medications while trying to manage side effects. New research suggests that using genetic testing to guide these choices could make the process much smoother for patients.
A study of 900 people with hypertension compared standard care to a guided approach. In the group that received guidance based on their specific genes, more people reached their blood pressure goals at both three and six months. This method also led to much higher rates of treatment compliance, meaning patients were more likely to stick with their prescribed plans.
Beyond just hitting numbers, the genetic approach significantly reduced common issues. Patients in the guided group had a much lower rate of dry coughs caused by their medication and required fewer drug adjustments during hospital stays. They also saw a lower rate of being readmitted to the hospital within six months. While this is still an early application of gene detection for hypertension, the results show it can improve how patients experience their treatment.
